| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
163,174 | 144,535 | 106,042 | 188,533 | 0 | - | 0 | 0 | - |
General and administrative | ||||||||
60,056 | 57,473 | 56,803 | 53,104 | 51,443 | 40,982 | 0 | 0 | 0 |
Total operating expenses | ||||||||
223,230 | 202,008 | 170,479 | 137,655 | 226,706 | 192,842 | 0 | 0 | 0 |
Loss from operations | ||||||||
-223,230 | -202,008 | -170,479 | -137,655 | -226,706 | -192,842 | 0 | 0 | 0 |
Other income (expense), net: | ||||||||
Change in fair value of convertible note payable | ||||||||
- | - | 0 | - | - | - | 0 | - | - |
Interest expense | ||||||||
- | - | 0 | - | - | - | 0 | - | - |
Interest and other income, net | ||||||||
15,787 | 17,351 | 15,156 | 10,957 | 0 | - | 0 | 0 | - |
Other expenses | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Total other income (expense), net | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Loss before income taxes | ||||||||
-207,769 | -184,925 | -154,366 | -147,161 | -240,661 | -211,622 | 0 | 0 | 0 |
Benefit from income taxes | ||||||||
-231 | -331 | -226 | -259 | 0 | - | 0 | 0 | - |
Net loss | ||||||||
-207,488 | -184,594 | -154,073 | -146,835 | -240,494 | -211,505 | 0 | 0 | 0 |
Other comprehensive income: | ||||||||
Net unrealized gain on available-for-sale investments | ||||||||
205 | 839 | 1,412 | 1,707 | 0 | - | 0 | 0 | - |
Net comprehensive loss | ||||||||
-207,283 | -183,755 | -152,059 | -144,674 | -239,089 | -211,199 | 0 | 0 | 0 |
Net loss per share, basic and diluted (in dollars per share) | ||||||||
-0.50 | -0.60 | -0.50 | -0.41 | -0.32 | 47.32 | -10.71 | -43.82 | -0.10 |
Weighted-average number of shares used in computing net loss per share, basic and diluted (in shares) | ||||||||
108,963 | 104,895 | 102,186 | 99,846 | 97,315 | 82,404 | 4,060 | 3,078 | 26,249 |